In deep-seated candidosis, evidence points to the existence of mannan antigen in the bloodstream (2, 11) . This antigen does not circulate freely but is bound by anti-Candida antibody and/or a recently characterized mannan-binding protein (9) . Efforts to detect circulating mannan antigen regularly in early stages of deep-seated candidosis have failed (11, 14, 20) . For Aspergillus galactomannan antigen, rapid clearance from the bloodstream, mediated by urinary excretion and hepatic uptake of the antigen, has been shown in rabbits and rats (3, 7) . In contrast, Cryptococcus glucuronoxylomannan (GluXM) antigen has been found to circulate in high quantities for prolonged periods in the bloodstreams of patients with AIDS and cryptococcosis (8) . Candida mannan antigenemia is fluctuating and transitory (11) .
A general mechanism for clearing fungal mannans from the bloodstream may consist of mannosyl receptors of macrophages (2) and liver sinusoidal endothelial cells (22) (23) (24) , which have a greater capacity to endocytose N-acetylglucosamine-and mannose-terminated glycoproteins than do Kupffer cells (21) . Fibronectin has a role in antigen and immune complex clearance from and uptake by tissues (6) . The clinical findings with mannan, galactomannan, and GluXM antigenemia in candidosis, aspergillosis, and cryptococcosis, respectively (7, 8, 11) , suggest differential clearance of the mannan antigens, depending on the side chains of the a(1-6)-or a(1-3)-linked mannose backbone of these polysaccharides. The side chains of Candida mannan antigen consist of (x(1-2)-and a(1-3)-linked mannose units (12) , those of Aspergillus galactomannan antigen consist of a(1-2)-and P(1-4)-linked galactose units (1) , and those of Crypto-glucuronic acid and ,(1-2)-linked xylose (4, 13) . The capsular polysaccharides of Cryptococcus neoformans contain a mixture of at least three heteroglycans. However, it appears certain that most, if not all, of the serotype specificity resides in the major acidic polysaccharide GluXM (15) . As a consequence, this study dealt with GluXM.
The fate of candidal and cryptococcal antigens in animal models has not been explored in detail. For Candida mannan antigen, this is due partly to the need for extraordinarily high doses to generate detectable antigen levels in serum. In this study, we examined the clearances of Candida mannan antigen and Cryptococcus GluXM antigen in nonimmune rabbits. Furthermore, we determined the fate of Candida mannan antigen in nonimmune mice after injection of ethanol-killed Candida blastospores and after lethal systemic infection with Candida albicans. (Fig. 1A) . Filtration of low-molecular-weight antigens in the urine paralleled circulation in the bloodstream (Fig. 1B) .
MATERIALS AND METHODS

Microorganisms
(ii) Cryptococcus GluXM antigen. One rabbit was injected intravenously with 20 jig of Cryptococcus antigen (1,000 times less than Candida antigen). A blood sample drawn 5 min before antigen injection was negative for cryptococcal antigen. Freely circulating antigen in untreated serum was never detectable. Pretreatment of serum samples resulted in prolonged demonstration of circulating protein-bound cryptococcal antigen (Fig. 2) . Urinary cryptococcal antigen was not detected (data not shown).
Candida mannan antigen clearance in mice. (i) Injection of soluble Candida mannan antigen. Twelve female BALB/c mice were each injected intravenously with 200 jig of Candida mannan antigen. At 5 and 18 h and days 2, 3, 4, 6, 8, 10, 15, 24, 56, and 97, one mouse each was sacrificed and blood and organs were examined for Candida antigen. As with rabbits, Candida mannan antigen was rapidly cleared from the bloodstream. Antigen titers in serum were 1:16 and 1:6 at 5 and 18 h, respectively, and negative on days 2, 3, 4, and 6. Antigen titers in kidneys, lungs, and hearts paralleled those in the serum. The titers in the right kidney, left kidney, right lung, left lung, and heart were 1:4, 1:4, 1:2, 1:1, and 1:1 at 5 h and 1:1, 1:1, 1:2, 1:1, and 1:1 at 18 h and all were negative on days 2 and 3. The antigen titers in liver and spleen were approximately 10 times higher (1:256 in the liver and 1:32 in the spleen at 5 h), they increased during the first 18 h (reaching 1:500 in the liver and 1:48 in the spleen at 18 h), and then they gradually dropped (with reciprocal liver titers of 128, 500, 500, 256, 500, 128, 128, 128, 32 and reciprocal spleen titers of 16, 32, 64, 32, 8, 32, 32, 8 , and 8 on days 2 to 56, respectively), persisting for as long as 97 days (liver titer, 1:8; spleen titer, 1:2). These data are not shown.
(ii) Injection of ethanol-killed C. albicans. Twenty-one female BALB/c mice were injected intravenously with 2 x 107 ethanol-killed C. albicans blastospores. At 2 and 7 h and 1, 2, 4, 14, and 28 days, three mice each were sacrificed and pretreated blood serum, livers, and spleens were examined for Candida antigen. Circulating Candida mannan antigen J. CLIN. MICROBIOL. dropped during the first 24 h, rose to a second peak on day 4, and thereafter gradually declined until day 28 (Fig. 3) . Candida antigen accumulated in livers and spleens, reaching maximum titers on days 4 and 14, respectively, followed by a gradual decline (Fig. 3) .
Candida viable counts and antigen in a lethal murine infection. Thirty male BALB/c mice were infected intravenously with 6 x 106 viable C. albicans blastospores, which represents a lethal dose. Five control mice received 0.5 ml of saline only. At (11, 14, 20) . Low sensitivity is due 10000 -l x 106 viable C. albicans organisms. CFU were determined by plate counts of serial dilutions of blood and organ homogenates (A). Antigen concentrations were calculated from antigen titer, LAT sensitivity (8 ng/ml), and organ weights (B) . The data represent means and standard errors of the means (SEM) of five mice with two cultures each.
to (i) a lower detection limit (generally above 1 ng/ml with common immunoassays) and (ii) fluctuant and transitory existence of Candida mannan antigen with different forms and stages of deep-seated candidosis (2, 11) . The first point may be overcome by more sensitive methods, but the second point may be a handicap even for methods with a sensitivity well in the picogram-per-milliliter range.
To understand better the transitory character of mannan antigenemia in deep-seated candidosis, we explored first the clearance of soluble mannan antigen after a single intravenous injection. To secure serum samples at least 300 ,ul in volume in short sequence, rabbits were used in these experiments. Since preliminary experiments had shown that lower quantities of Candida antigen were cleared too rapidly to result in proper elimination data, we injected as much as 20 mg of Candida mannan antigen. In summary, clearance data of three rabbits allowed estimation of the serum half-life of Candida mannan antigen in rabbits as approximately 2 h (Fig. 1A) . In contrast, with Cryptococcus GluXM antigen we injected 20 ,ug, i.e., 1,000 times less than with Candida mannan antigen. Nevertheless, we not only detected the antigen in the early phase but also showed its persistence for up to 48 h (Fig. 2) , which indicates a serum half-life on the order of 24 h. These findings support the hypothesis that fungal mannan antigens are cleared by mannosyl receptors (2), since it predicts that Candida mannan antigen, which has mannose units on the surface (12) , is cleared more rapidly than Cryptococcus GluXM antigen, which has mainly glucuronic acid and xylose on the surface (4, 13, 15) . Candida mannan antigen was shown to exist in urine samples, roughly reflecting the amount of circulating mannan antigen (Fig. 1B) . Cryptococcal antigen was not detected in urine samples, probably because of the low injection dose of 20 ,ug with subsequent low titers in the serum. Candida mannan antigen does have low-molecular-mass portions below 30 kDa, the cutoff of the glomerular basement membrane. Our data suggest passive glomerular filtration of low-molecularmass Candida mannan antigen rather than active renal excretion. The considerable amount of urinary antigen, as estimated from urine titers and volumes, compared with the small low-molecular-mass portion of the original mannan antigen (approximately 5%), suggests that Candida mannan antigen is subject to partial in vivo breakdown.
To study the distribution of cleared Candida mannan antigen in organs and clearance from the organs further, we injected mice intravenously with a single dose of 200 p.g of soluble Candida mannan antigen. As already shown with rabbits, Candida mannan antigen was rapidly cleared from the bloodstream and not detected in serum samples thereafter. At 5 and 18 h, low antigen titers in the kidneys, lungs, and heart reflected contamination of these organs with serum. In contrast, antigen titers approximately 10 times higher in the liver and spleen increased during the first 18 h. Thus, Candida mannan antigen is cleared from the circulation mainly by the liver and spleen and to a lesser extent by renal filtration. Clearance from the liver and spleen was delayed, as indicated by persisting antigen titers in these organs on day 97 (data not shown). Thus, in vivo breakdown of Candida mannan antigen in the livers and spleens of mice appears to be very limited.
To check these results under conditions closer to the infectious situation, in which mannan is released from intact Candida cells, we injected mice intravenously with 2 x 107 ethanol-killed C. albicans blastospores. By using dead Candida organisms, we were able to inject a dose high enough to allow detailed studies of titers in serum and a prolonged follow-up, undisturbed by Candida multiplication, additional mannan turnover, or premature death of mice. Circulating Candida mannan antigen dropped dramatically during the first 24 h, rose to a second peak on day 4, and thereafter gradually declined until day 28 (Fig. 3) . The second peak of circulating Candida mannan antigen on day 4, which did not appear after injection of soluble antigen alone, is probably due to release of mannan antigen from Candida cells already cleared from the circulation by the liver and spleen. As we took no measurements between days 4 and 14, the true peak of circulating antigen may have occurred at any time between days 2 and 14. Accumulation of Candida antigen in liver and spleen, followed by a delayed breakdown, confirmed the previous results obtained with soluble antigen.
To approach the infectious situation as closely as possible, we finally chose a model of acute lethal systemic Candida infection in mice. This model is characterized by a complex array of processes, which all influence the antigen levels in Candida foci in organs, (iii) antigen release, and (iv) death of mice. We avoided a model of subacute, nonlethal candidosis, because in preliminary experiments antigen levels had been very low to undetectable, and we accepted the limitation of the study period due to early death of the mice. Negative blood cultures as early as 48 h after infection confirm the unsuitability of blood cultures for the diagnosis of deep-seated candidosis. Viable Candida burdens of the liver and spleen also dropped during the first 24 h. However, there was no complete elimination of viable Candida organisms, thus leaving a source of continuous antigen release and leading to persisting antigenemia. By day 3, mannan concentrations in the liver and spleen had increased significantly (Fig. 4B) , probably because of trapped antigen released from Candida foci of other organs. Urinary antigen titers were lower than antigen titers in serum, and antigenuria neither preceded nor outlasted antigenemia. Thus, our data do not confirm any advantage of urinary antigen testing over serum antigen testing, as has been suggested for several disseminated fungal diseases, including candidosis (10), aspergillosis (7), and histoplasmosis (25) .
We did not examine fungal antigen clearances in immune animals. Most patients at risk for deep-seated candidosis do have circulating anticandidal immunoglobulins G, M, and A.
Circulating immune complexes have been demonstrated in association with human candidosis (5, 14) , and release of specific mannan antigen-antibody complexes has been shown by immune electron microscopy in chronic human vaginal candidosis (16) . Thus, Fc receptors of liver sinusoidal endothelium (18) will'play a considerable additional part in the clearance of Candida immune complexes from the circulation of patients.
Our model of lethal infection provides further evidence for the existence of circulating mannan antigen in disseminated candidosis. However, persistently measurable antigen levels could be generated only by an infective dose far beyond the 50% lethal dose. This corresponds to the clinical observation of regular antigenemia only in patients with terminal overwhelming disseminated candidosis (11) .
With many clinical cases of deep-seated candidosis, especially early stages and diseases confined to certain organs, mannan clearance will be more effective than release of mannan antigen from Candida foci into the circulation. Therefore, some patients suffering from deep-seated candidosis may never enter a mannan turnover state, which could result in persistent circulating antigen levels.
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